{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:51:49Z","timestamp":1791305509976,"version":"4.3.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Amiodarone or lidocaine are recommended for the treatment of shockable out-of-hospital cardiac arrest (OHCA). Previous comparisons between the two antiarrhythmic drugs were inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>This analysis included data from the Resuscitation Outcomes Consortium Cardiac Epidemiologic Registry 3 (2011\u20132015). A target trial framework was used to overcome confounding inherent in observational comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Data from patients with OHCA were prospectively collected by emergency medical services (EMS) at multiple North American sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Adults with nontraumatic OHCA and an initial shockable rhythm who received at least three defibrillation attempts were included. Time zero was defined as first antiarrhythmic drug administration, at which eligibility criteria had to be met.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>Two antiarrhythmic treatment strategies were compared: lidocaine vs. amiodarone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>The primary outcome was survival to hospital discharge. The key secondary outcome was favorable neurologic outcome at discharge (modified Rankin scale score of 3 or less). Group differences were adjusted using inverse probability weighting (key covariates: age, sex, location of OHCA, witness status, bystander resuscitation, automated external defibrillator shock, elapsed time from call to advanced life support arrival\/first EMS shock\/advanced airway, intraosseous access) and a multiple logistic regression model. Of 2451 patients included, 987 received lidocaine and 1464 received amiodarone. The adjusted percentage point difference in survival to hospital discharge was 2.8% favoring lidocaine (95% CI, \u20130.6 to 6.2); the estimated survival probabilities were 26.2% (275\/987) with lidocaine and 23.5% (329\/1464) with amiodarone. No difference was observed in the estimated probability of favorable neurologic outcome at discharge between the lidocaine group (17.7%) and the amiodarone group (16.2%) (adjusted difference, 1.5%; 95% CI, \u20131.5 to 4.5).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>No statistically significant difference in survival or favorable neurologic outcome was observed between lidocaine and amiodarone; however, the wide CIs cannot exclude a clinically meaningful benefit for lidocaine. These findings are consistent with randomized controlled trials, but residual confounding cannot be excluded.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007265","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:00:11Z","timestamp":1784149211000},"page":"2579-2589","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation"],"prefix":"10.1097","volume":"54","author":[{"given":"Georg","family":"Gelbenegger","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Cheskes","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada."},{"name":"Sunnybrook Centre for Prehospital Medicine, Toronto, ON, Canada."},{"name":"Sunnybrook Research Institute and Department of Emergency Services, Sunnybrook Health Science Centre, Toronto, ON, Canada."},{"name":"Department of Family and Community Medicine, Division of Emergency Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Drennan","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute and Department of Emergency Services, Sunnybrook Health Science Centre, Toronto, ON, Canada."},{"name":"Department of Family and Community Medicine, Division of Emergency Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada."},{"name":"Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon C.","family":"Scales","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"R1-20261006","doi-asserted-by":"crossref","first-page":"109757","DOI":"10.1016\/j.resuscitation.2023.109757","article-title":"Three-year trends in out-of-hospital cardiac arrest across the world: Second report from the International Liaison Committee on Resuscitation (ILCOR).","volume":"186","author":"Nishiyama","year":"2023","journal-title":"Resuscitation"},{"key":"R2-20261006","doi-asserted-by":"crossref","first-page":"109786","DOI":"10.1016\/j.resuscitation.2023.109786","article-title":"Trends in out-of-hospital cardiac arrest across the world: Additional data from the CanROC and ReAC national registries.","volume":"187","author":"Heidet","year":"2023","journal-title":"Resuscitation"},{"key":"R3-20261006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0300-9572(99)00155-0","article-title":"Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in Sweden.","volume":"44","author":"Holmberg","year":"2000","journal-title":"Resuscitation"},{"key":"R4-20261006","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.resuscitation.2020.09.029","article-title":"Time to change the times? Time of recurrence of ventricular fibrillation during OHCA.","volume":"157","author":"Spies","year":"2020","journal-title":"Resuscitation"},{"key":"R5-20261006","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N Engl J Med"},{"key":"R6-20261006","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.","volume":"346","author":"Dorian","year":"2002","journal-title":"N Engl J Med"},{"key":"R7-20261006","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1514204","article-title":"Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest.","volume":"374","author":"Kudenchuk","year":"2016","journal-title":"N Engl J Med"},{"key":"R8-20261006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13063-024-07935-y","article-title":"Pragmatic randomized controlled trials: Strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.","volume":"25","author":"Omerovic","year":"2024","journal-title":"Trials"},{"key":"R9-20261006","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.chest.2022.10.024","article-title":"Comparative effectiveness of amiodarone and lidocaine for the treatment of in-hospital cardiac arrest.","volume":"163","author":"Wagner","year":"2023","journal-title":"Chest"},{"key":"R10-20261006","doi-asserted-by":"crossref","first-page":"110515","DOI":"10.1016\/j.resuscitation.2025.110515","article-title":"A retrospective \u2018target trial emulation\u2019 comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation.","volume":"208","author":"Smida","year":"2025","journal-title":"Resuscitation"},{"issue":"Suppl 1","key":"R11-20261006","doi-asserted-by":"crossref","first-page":"110769","DOI":"10.1016\/j.resuscitation.2025.110769","article-title":"European resuscitation council guidelines 2025 adult advanced life support.","volume":"215","author":"Soar","year":"2025","journal-title":"Resuscitation"},{"issue":"16_Suppl_2","key":"R12-20261006","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1161\/CIR.0000000000001376","article-title":"Part 9: Adult Advanced Life Support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.","volume":"152","author":"Wigginton","year":"2025","journal-title":"Circulation"},{"key":"R13-20261006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.resuscitation.2008.02.020","article-title":"Rationale, development and implementation of the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.","volume":"78","author":"Morrison","year":"2008","journal-title":"Resuscitation"},{"key":"R14-20261006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamainternmed.2024.8129","article-title":"Emulating a target trial using observational data.","volume":"185","author":"Dib","year":"2025","journal-title":"JAMA Intern Med"},{"key":"R15-20261006","doi-asserted-by":"crossref","first-page":"e071108","DOI":"10.1136\/bmj-2022-071108","article-title":"Target trial emulation: Applying principles of randomised trials to observational studies.","volume":"378","author":"Matthews","year":"2022","journal-title":"BMJ"},{"key":"R16-20261006","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial\u2014the TARGET statement.","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"issue":"18 Suppl 3","key":"R17-20261006","first-page":"S729","article-title":"Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.","volume":"122","author":"Neumar","year":"2010","journal-title":"Circulation"},{"key":"R18-20261006","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/CIRCULATIONAHA.113.002408","article-title":"Duration of resuscitation efforts and functional outcome after out-of-hospital cardiac arrest: When should we change to novel therapies?","volume":"128","author":"Reynolds","year":"2013","journal-title":"Circulation"},{"key":"R19-20261006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: Results of an empirical investigation and Monte Carlo simulations.","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"R20-20261006","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects.","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R21-20261006","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.resuscitation.2014.07.011","article-title":"Survival rates in out-of-hospital cardiac arrest patients transported without prehospital return of spontaneous circulation: An observational cohort study.","volume":"85","author":"Drennan","year":"2014","journal-title":"Resuscitation"},{"key":"R22-20261006","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10903127.2012.695435","article-title":"Cardiac arrest survival is rare without prehospital return of spontaneous circulation.","volume":"16","author":"Wampler","year":"2012","journal-title":"Prehosp Emerg Care"},{"key":"R23-20261006","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/heartjnl-2021-320513","article-title":"Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.","volume":"108","author":"Lane","year":"2022","journal-title":"Heart"},{"key":"R24-20261006","doi-asserted-by":"crossref","first-page":"e023958","DOI":"10.1161\/JAHA.121.023958","article-title":"Effect of time to treatment with antiarrhythmic drugs on return of spontaneous circulation in shock-refractory out-of-hospital cardiac arrest.","volume":"11","author":"Rahimi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R25-20261006","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/CCM.0000000000005846","article-title":"The effect of time to treatment with antiarrhythmic drugs on survival and neurological outcomes in shock refractory out-of-hospital cardiac arrest.","volume":"51","author":"Rahimi","year":"2023","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:17Z","timestamp":1791302477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007265","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}